If Anixa exercises its rights, Verdi and Anixa will collaborate on trials in the US, while Verdi will continue developing personalized vaccines in Europe.

Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides data-driven tools and resources to improve cancer care. To streamline the ...

The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.

In addition to its scientific sessions, PathAI will host H&E by the Sea, an AI-powered pathology networking event on March 25 th at 6:00 p.m. ET at the Nautilus Pier 4. The event will bring together ...

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...

The emergence of degrader-antibody conjugates (DACs) has attracted much attention, with a potential to transform the ...

Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium ...

Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, today announced the expansion of its US patent portfolio. Strengthening its cardiometabolic treatment portfolio, the Company now ...